Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients

Figure 8

Freedom from overall allograft rejection (a), ABMR (b), and CMR (c) in DES (blue) versus non-DES (red) patients during the 1st 5 years after transplant. The group differences were assessed by the log-rank test.

(a) Allograft rejection (ABMR or CMR)

(b) ABMR

(c) CMR